Jeffrey Sevigny SEC EDGAR Filings (CIK 0001778483)

SEC EDGAR filings, ownership reports, and insider transactions for Jeffrey Sevigny.

Business address
C/O Prevail Therapeutics Inc., 430 East 29 Th Street, Suite 940, New York, NY, 10016
Get insider transactions for this reporting owner
Jeffrey Sevigny has filed 8 SEC EDGAR filings since 19 Jun 2019

Latest Filings

Recent SEC filings for Jeffrey Sevigny including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 03 Apr 2025 01 Apr 2025 001-42121
3 Open 3 document View SEC filing for 3 3 05 Mar 2025 03 Mar 2025 001-42121
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 17 Jun 2022 15 Jun 2022 001-40551
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 02 Jul 2021 30 Jun 2021 001-40551
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 30 Jun 2021 30 Jun 2021 001-40551
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 Jan 2021 22 Jan 2021 001-38939
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 11 Mar 2020 19 Feb 2020 001-38939
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 19 Jun 2019 19 Jun 2019 001-38939

About this filer

Jeffrey Sevigny files with the SEC under CIK 0001778483. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages